Cargando…

Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study

BACKGROUND: Little is known about the long-term health effects of ambient ultrafine particles (<0.1 μm) (UFPs) including their association with respiratory disease incidence. In this study, we examined the relationship between long-term exposure to ambient UFPs and the incidence of lung cancer, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Weichenthal, Scott, Bai, Li, Hatzopoulou, Marianne, Van Ryswyk, Keith, Kwong, Jeffrey C., Jerrett, Michael, van Donkelaar, Aaron, Martin, Randall V., Burnett, Richard T., Lu, Hong, Chen, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477122/
https://www.ncbi.nlm.nih.gov/pubmed/28629362
http://dx.doi.org/10.1186/s12940-017-0276-7
_version_ 1783244729040764928
author Weichenthal, Scott
Bai, Li
Hatzopoulou, Marianne
Van Ryswyk, Keith
Kwong, Jeffrey C.
Jerrett, Michael
van Donkelaar, Aaron
Martin, Randall V.
Burnett, Richard T.
Lu, Hong
Chen, Hong
author_facet Weichenthal, Scott
Bai, Li
Hatzopoulou, Marianne
Van Ryswyk, Keith
Kwong, Jeffrey C.
Jerrett, Michael
van Donkelaar, Aaron
Martin, Randall V.
Burnett, Richard T.
Lu, Hong
Chen, Hong
author_sort Weichenthal, Scott
collection PubMed
description BACKGROUND: Little is known about the long-term health effects of ambient ultrafine particles (<0.1 μm) (UFPs) including their association with respiratory disease incidence. In this study, we examined the relationship between long-term exposure to ambient UFPs and the incidence of lung cancer, adult-onset asthma, and chronic obstructive pulmonary disease (COPD). METHODS: Our study cohort included approximately 1.1 million adults who resided in Toronto, Canada and who were followed for disease incidence between 1996 and 2012. UFP exposures were assigned to residential locations using a land use regression model. Random-effect Cox proportional hazard models were used to estimate hazard ratios (HRs) describing the association between ambient UFPs and respiratory disease incidence adjusting for ambient fine particulate air pollution (PM(2.5)), NO(2), and other individual/neighbourhood-level covariates. RESULTS: In total, 74,543 incident cases of COPD, 87,141 cases of asthma, and 12,908 cases of lung cancer were observed during follow-up period. In single pollutant models, each interquartile increase in ambient UFPs was associated with incident COPD (HR = 1.06, 95% CI: 1.05, 1.09) but not asthma (HR = 1.00, 95% CI: 1.00, 1.01) or lung cancer (HR = 1.00, 95% CI: 0.97, 1.03). Additional adjustment for NO(2) attenuated the association between UFPs and COPD and the HR was no longer elevated (HR = 1.01, 95% CI: 0.98, 1.03). PM(2.5) and NO(2) were each associated with increased incidence of all three outcomes but risk estimates for lung cancer were sensitive to indirect adjustment for smoking and body mass index. CONCLUSIONS: In general, we did not observe clear evidence of positive associations between long-term exposure to ambient UFPs and respiratory disease incidence independent of other air pollutants. Further replication is required as few studies have evaluated these relationships. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12940-017-0276-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5477122
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54771222017-06-22 Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study Weichenthal, Scott Bai, Li Hatzopoulou, Marianne Van Ryswyk, Keith Kwong, Jeffrey C. Jerrett, Michael van Donkelaar, Aaron Martin, Randall V. Burnett, Richard T. Lu, Hong Chen, Hong Environ Health Research BACKGROUND: Little is known about the long-term health effects of ambient ultrafine particles (<0.1 μm) (UFPs) including their association with respiratory disease incidence. In this study, we examined the relationship between long-term exposure to ambient UFPs and the incidence of lung cancer, adult-onset asthma, and chronic obstructive pulmonary disease (COPD). METHODS: Our study cohort included approximately 1.1 million adults who resided in Toronto, Canada and who were followed for disease incidence between 1996 and 2012. UFP exposures were assigned to residential locations using a land use regression model. Random-effect Cox proportional hazard models were used to estimate hazard ratios (HRs) describing the association between ambient UFPs and respiratory disease incidence adjusting for ambient fine particulate air pollution (PM(2.5)), NO(2), and other individual/neighbourhood-level covariates. RESULTS: In total, 74,543 incident cases of COPD, 87,141 cases of asthma, and 12,908 cases of lung cancer were observed during follow-up period. In single pollutant models, each interquartile increase in ambient UFPs was associated with incident COPD (HR = 1.06, 95% CI: 1.05, 1.09) but not asthma (HR = 1.00, 95% CI: 1.00, 1.01) or lung cancer (HR = 1.00, 95% CI: 0.97, 1.03). Additional adjustment for NO(2) attenuated the association between UFPs and COPD and the HR was no longer elevated (HR = 1.01, 95% CI: 0.98, 1.03). PM(2.5) and NO(2) were each associated with increased incidence of all three outcomes but risk estimates for lung cancer were sensitive to indirect adjustment for smoking and body mass index. CONCLUSIONS: In general, we did not observe clear evidence of positive associations between long-term exposure to ambient UFPs and respiratory disease incidence independent of other air pollutants. Further replication is required as few studies have evaluated these relationships. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12940-017-0276-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-19 /pmc/articles/PMC5477122/ /pubmed/28629362 http://dx.doi.org/10.1186/s12940-017-0276-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Weichenthal, Scott
Bai, Li
Hatzopoulou, Marianne
Van Ryswyk, Keith
Kwong, Jeffrey C.
Jerrett, Michael
van Donkelaar, Aaron
Martin, Randall V.
Burnett, Richard T.
Lu, Hong
Chen, Hong
Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study
title Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study
title_full Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study
title_fullStr Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study
title_full_unstemmed Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study
title_short Long-term exposure to ambient ultrafine particles and respiratory disease incidence in in Toronto, Canada: a cohort study
title_sort long-term exposure to ambient ultrafine particles and respiratory disease incidence in in toronto, canada: a cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477122/
https://www.ncbi.nlm.nih.gov/pubmed/28629362
http://dx.doi.org/10.1186/s12940-017-0276-7
work_keys_str_mv AT weichenthalscott longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT baili longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT hatzopouloumarianne longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT vanryswykkeith longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT kwongjeffreyc longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT jerrettmichael longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT vandonkelaaraaron longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT martinrandallv longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT burnettrichardt longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT luhong longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy
AT chenhong longtermexposuretoambientultrafineparticlesandrespiratorydiseaseincidenceinintorontocanadaacohortstudy